Notice of Draft Document for Public Comment, 20209 [2014-08141]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 70 / Friday, April 11, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
[CDC–2014–0006, Docket Number NIOSH–
273]
Notice of Draft Document for Public
Comment
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of draft document for
public comment.
AGENCY:
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention announces the availability of
a draft method to be published in the
NIOSH Manual of Analytical Methods
(NMAM) entitled ‘‘Method 8324: 3Bromopropionic acid in urine; A
metabolite of 1-bromopropane’’ now
available for public comment. To view
the notice and related materials, visit
https://www.regulations.gov and enter
CDC–2014–0006 in the search field and
click ‘‘Search.’’
Public comment period: Comments
must be received June 10, 2014.
ADDRESSES: You may submit comments,
identified by CDC–2014–0006 and
Docket Number NIOSH–273, by either
of the following two methods:
• Federal eRulemaking Portal:
https://www.regulations.gov Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, 4676 Columbia
Parkway, MS C–34, Cincinnati, Ohio
45226.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2014–0006; NIOSH–273]. All
relevant comments received will be
posted without change https://
www.regulations.gov, including any
personal information provided. All
information received in response to this
notice will also be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Room 109, Cincinnati, OH 45226.
SUPPLEMENTARY INFORMATION:
Background: The NIOSH Manual of
Analytical Methods (NMAM) was first
published in 1974 and currently
contains over 300 methods that can be
used by the occupational safety and
health community to measure worker
exposures. 1-Bromopropane is an
industrial solvent often used as a
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:55 Apr 10, 2014
Jkt 232001
substitute for a number of
chlorofluorocarbon solvents which were
withdrawn from use because of their
possible damaging effects to the ozone
layer. 3-Bromopropionic acid is a
human metabolite of 1-bromopropane
and a proposed biomarker of exposure.
An accurate and precise method was
developed for the detection and
quantitation of 3-bromopropionic acid
in human urine. This method was
published in the literature (B’Hymer CB,
Cheever KL [2004]. J Chromatogr B
802:361–366). The method was
validated by a second laboratory and is
proposed for inclusion in NMAM’s 5th
Edition.
FOR FURTHER INFORMATION CONTACT: Dale
Shoemaker, Ph.D., NIOSH DART, 4676
Columbia Parkway MS R–7, Cincinnati,
OH 45226. (513) 841–4523.
Dated: April 7, 2014.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2014–08141 Filed 4–10–14; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee:
Times and Dates: 11:00 a.m.–5:30 p.m.,
May 12, 2014, 8:30 a.m.–1:00 p.m., May 13,
2014
Place: NCHS Headquarters, 3311 Toledo
Road, Hyattsville, Maryland 20782.
Status: This meeting is open to the public;
however, visitors must be processed in
accordance with established federal policies
and procedures. For foreign nationals or nonUS citizens, pre-approval is required (please
contact Gwen Mustaf, 301–458–4500, glm4@
cdc.gov, or Virginia Cain, vcain@cdc.gov at
least 10 days in advance for requirements).
All visitors are required to present a valid
form of picture identification issued by a
state, federal or international government. As
required by the Federal Property
Management Regulations, Title 41, Code of
Federal Regulation, Subpart 101–20.301, all
persons entering in or on Federal controlled
property and their packages, briefcases, and
other containers in their immediate
possession are subject to being x-rayed and
inspected. Federal law prohibits the knowing
possession or the causing to be present of
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
20209
firearms, explosives and other dangerous
weapons and illegal substances. The meeting
room accommodates approximately 100
people.
Purpose: This committee is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human Services;
the Director, CDC; and the Director, NCHS,
regarding the scientific and technical
program goals and objectives, strategies, and
priorities of NCHS.
Matters For Discussion: The agenda will
include welcome remarks by the Director,
NCHS; the March 4–5, 2014 Office of
Analysis and Epidemiology Program Review;
report from the February 10–11, 2014
National Academy of Sciences Workshop on
Guidelines for Returning Individual Results
from Genome Research Using PopulationBased Specimens; program updates.
Requests to make oral presentations should
be submitted in writing to the contact person
listed below. All requests must contain the
name, address, telephone number, and
organizational affiliation of the presenter.
Written comments should not exceed five
single-spaced typed pages in length and must
be received by April 25, 2014.
The agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7208, Hyattsville,
Maryland 20782, telephone (301) 458–4500,
fax (301) 458–4020. The Director,
Management Analysis and Services Office,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities for both the
Centers for Disease Control and the Agency
for Toxic Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–08199 Filed 4–10–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–37, CMS–64,
CMS–10320, CMS–10396, CMS–102 and
CMS–105, and CMS–367]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
SUMMARY:
E:\FR\FM\11APN1.SGM
11APN1
]]>Agencies
[Federal Register Volume 79, Number 70 (Friday, April 11, 2014)]
[Notices]
[Page 20209]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08141]
[[Page 20209]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
[CDC-2014-0006, Docket Number NIOSH-273]
Notice of Draft Document for Public Comment
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of draft document for public comment.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health of
the Centers for Disease Control and Prevention announces the
availability of a draft method to be published in the NIOSH Manual of
Analytical Methods (NMAM) entitled ``Method 8324: 3-Bromopropionic acid
in urine; A metabolite of 1-bromopropane'' now available for public
comment. To view the notice and related materials, visit https://www.regulations.gov and enter CDC-2014-0006 in the search field and
click ``Search.''
Public comment period: Comments must be received June 10, 2014.
ADDRESSES: You may submit comments, identified by CDC-2014-0006 and
Docket Number NIOSH-273, by either of the following two methods:
Federal eRulemaking Portal: https://www.regulations.gov
Follow the instructions for submitting comments.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
4676 Columbia Parkway, MS C-34, Cincinnati, Ohio 45226.
Instructions: All information received in response to this notice
must include the agency name and docket number [CDC-2014-0006; NIOSH-
273]. All relevant comments received will be posted without change
https://www.regulations.gov, including any personal information
provided. All information received in response to this notice will also
be available for public examination and copying at the NIOSH Docket
Office, 4676 Columbia Parkway, Room 109, Cincinnati, OH 45226.
SUPPLEMENTARY INFORMATION:
Background: The NIOSH Manual of Analytical Methods (NMAM) was first
published in 1974 and currently contains over 300 methods that can be
used by the occupational safety and health community to measure worker
exposures. 1-Bromopropane is an industrial solvent often used as a
substitute for a number of chlorofluorocarbon solvents which were
withdrawn from use because of their possible damaging effects to the
ozone layer. 3-Bromopropionic acid is a human metabolite of 1-
bromopropane and a proposed biomarker of exposure. An accurate and
precise method was developed for the detection and quantitation of 3-
bromopropionic acid in human urine. This method was published in the
literature (B'Hymer CB, Cheever KL [2004]. J Chromatogr B 802:361-366).
The method was validated by a second laboratory and is proposed for
inclusion in NMAM's 5th Edition.
FOR FURTHER INFORMATION CONTACT: Dale Shoemaker, Ph.D., NIOSH DART,
4676 Columbia Parkway MS R-7, Cincinnati, OH 45226. (513) 841-4523.
Dated: April 7, 2014.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2014-08141 Filed 4-10-14; 8:45 am]
BILLING CODE 4163-19-P
